Illustration of semaglutide (red) activating a key receptor, called GLP-1 (blue)
JUAN GAERTNER/SCIENCE PHOTO LIBRARY/Alamy
The active ingredient in Ozempic and Wegovy, a drug called semaglutide, can have direct beneficial effects on the heart within weeks, in addition to the longer-term benefits of losing weight, an animal study has shown.
The finding suggests that people with heart disease who don’t have type 2 diabetes or obesity, which semaglutide is primarily used to treat, might also benefit from taking this kind of drug. “It may be that we’re missing a…
Felecia Phillips Ollie DD (h.c.) is the inspiring leader and founder of The Equality Network LLC (TEN). With a background in coaching, travel, and a career in news, Felecia brings a unique perspective to promoting diversity and inclusion. Holding a Bachelor’s Degree in English/Communications, she is passionate about creating a more inclusive future. From graduating from Mississippi Valley State University to leading initiatives like the Washington State Department of Ecology’s Equal Employment Opportunity Program, Felecia is dedicated to making a positive impact. Join her journey on our blog as she shares insights and leads the charge for equity through The Equality Network.
